Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies
Mario Habek, Željko Cvetić, Ana Savić Mlakar, Krešo Bendelja, Dunja Rogić, Ivan Adamec, Barbara Barun, Tereza Gabelić, Magdalena Krbot Skorić
Topics & Concepts
MedicineOcrelizumabImmunologyMultiple sclerosisCellular immunityImmunitySeroconversionVaccinationHumoral immunityCoronavirus disease 2019 (COVID-19)AntibodyVirologyDiseaseImmune systemInternal medicineInfectious disease (medical specialty)RituximabSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19Multiple Sclerosis Research Studies